What are tumor markers and how reliable are they
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Tumor Markers: What They Are and How Reliable They Are
What Are Tumor Markers?
Tumor markers are substances—usually proteins—that are produced by cancer cells or by your body in response to cancer. They can be found in your blood, urine, or tissue samples. Think of them as chemical "signals" that may indicate cancer is present or how it's responding to treatment.
Common examples include:
- PSA (prostate-specific antigen) for prostate cancer
- CEA (carcinoembryonic antigen) for colorectal and other cancers
- CA-125 for ovarian cancer
- HER2 for breast cancer
- EGFR mutations for lung cancer
How Reliable Are They? (The Honest Answer)
Tumor markers are helpful tools, but they're NOT perfect screening or diagnostic tests. Here's why:
✅ What They Do Well:
- Monitor treatment response: If a marker drops during treatment, that's usually a good sign
- Detect recurrence: Rising levels after treatment may suggest cancer has returned
- Provide prognostic information: Some markers help predict how aggressive a cancer might be
- Guide treatment decisions: Certain markers (like HER2 or EGFR mutations) directly determine which targeted therapies might work
⚠️ Their Limitations:
- False positives: Non-cancer conditions can raise marker levels (inflammation, benign diseases, even pregnancy)
- False negatives: Some people with cancer have normal marker levels
- Not diagnostic alone: A high tumor marker doesn't confirm cancer by itself
- Variable reliability: Some markers are more reliable than others
How Doctors Actually Use Them
According to ASCO (American Society of Clinical Oncology) Guidelines, tumor markers work best when combined with other information:
- Diagnosis: Usually NOT used alone—imaging and biopsies are more definitive
- Prognosis: Help predict outcomes when measured at diagnosis
- Treatment monitoring: Most useful during and after treatment to track response
- Recurrence detection: Can help identify cancer returning before symptoms appear
The Bottom Line
Think of tumor markers like a dashboard warning light in your car—they alert you to something that needs attention, but the light alone doesn't tell you exactly what's wrong. Your doctor needs to combine marker results with imaging, biopsies, and clinical examination to make decisions.
According to the American Cancer Society, the most reliable use of tumor markers is:
- Tracking changes over time in the same person (rather than looking at a single number)
- Using them alongside other diagnostic tools
- Interpreting them in the context of your complete clinical picture
Questions to Ask Your Doctor About Your Markers:
- Which tumor markers are relevant to my specific cancer type?
- How often should we check my markers, and what changes would be concerning?
- What does my current marker level tell us compared to my baseline?
- Are there other tests (imaging, physical exam) we should do alongside marker testing?
- How will you use my marker results to guide my treatment decisions?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2
It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated
Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter